MicroRNAs (miRNAs) are small non-coding RNAs approximately 21 nucleotides in length that regulate gene expression at the post-transcriptional level by inducing mRNA destabilization and translational inhibition of target mRNAs. In humans, more than 2000 miRNAs have been identified and are thought to control a variety of biological processes development and cancer. The goal of this competitive renewal application is to continue our investigation of the biological functions and the oncogenic properties of the polycistronic miR-17~92 miRNA cluster, also known as Oncomir1. The miR- 17~92 cluster contains six miRNAs (miR-17, miR-18a, miR-19a, miR-19b, miR-20a, and miR-92) that can be grouped, based on sequence similarity, in four distinct subfamilies: miR-17 (includes miR-17 and miR-20a), miR-18, miR-19 (includes miR-19a and miR-19b), and miR-92a. During the past five years, supported by the NIH/NCI grant R01 CA149707, my group has performed a careful, and unprecedented, genetic dissection of this polycistronic cluster by generating an characterizing an allelic series of six genetically engineered mouse strains, each carrying selective targeted deletion of individual components of miR-17~92. This analysis, has lead to several important findings, including the discovery of causal role for miR-17 in skeletogenesis and axial patterning, the identification of germline mutations of miR- 17~92 as the cause of a human developmental syndrome known as Feingold Syndrome, and the discovery that the miR-19 family of miRNAs plays a key role in the pathogenesis of Myc-driven human cancers. These exciting new findings have lead to a series of novel hypotheses that are at the core of this grant renewal application. We propose a series of experiments that can be grouped into the following specific aims.
The first aim has the goal of investigating the molecular mechanisms through which miR-19 contributes to Myc- driven tumorigenesis. We will also test the recently proposed hypothesis that miR-92 functionally antagonizes miR-19 by acting as a tumor suppressor. In the second aim, we will test a novel pharmacologic approach to inhibit miR-19 in vivo based on a recently developed technology that allows targeted delivery of miRNA antagonists to the acidic tumor microenvironment. In the third aim, we will develop a novel and more efficient method to experimentally identify miRNA-mRNA interactions directly in vivo. Successful completion of the experiments described in this grant application would greatly advance our understanding of this important miRNA cluster in particular, and of miRNAs in general, and could lead to novel anticancer approaches.

Public Health Relevance

MicroRNAs are a class of small non-coding RNAs and act as key regulators of gene expression, thereby modulating virtually every biological process, including cancer development. In this grant renewal application we propose to continue our ongoing investigation of the miR-17~92 cluster of miRNAs, also known Oncomir-1. Achieving the objectives outlined in this proposal will greatly advance our understanding of the molecular mechanisms through which non-coding RNAs affect cancer initiation and progression and might lead to novel therapeutic options for the large number of human cancers in which miR-17~92 cluster is amplified or over- expressed.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Cancer Molecular Pathobiology Study Section (CAMP)
Program Officer
Fingerman, Ian M
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Sloan-Kettering Institute for Cancer Research
New York
United States
Zip Code
Schaub, Franz X; Dhankani, Varsha; Berger, Ashton C et al. (2018) Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas. Cell Syst 6:282-300.e2
Fiori, E; Babicola, L; Andolina, D et al. (2015) Neurobehavioral Alterations in a Genetic Murine Model of Feingold Syndrome 2. Behav Genet 45:547-59
Han, Yoon-Chi; Vidigal, Joana A; Mu, Ping et al. (2015) An allelic series of miR-17 ? 92-mutant mice uncovers functional specialization and cooperation among members of a microRNA polycistron. Nat Genet 47:766-75
Vidigal, Joana A; Ventura, Andrea (2015) The biological functions of miRNAs: lessons from in vivo studies. Trends Cell Biol 25:137-47
La Rocca, Gaspare; Olejniczak, Scott H; González, Alvaro J et al. (2015) In vivo, Argonaute-bound microRNAs exist predominantly in a reservoir of low molecular weight complexes not associated with mRNA. Proc Natl Acad Sci U S A 112:767-72
Zindy, Frederique; Kawauchi, Daisuke; Lee, Youngsoo et al. (2014) Role of the miR-17?92 cluster family in cerebellar and medulloblastoma development. Biol Open 3:597-605
Vidigal, Joana Alves; Ventura, Andrea (2012) Embryonic stem cell miRNAs and their roles in development and disease. Semin Cancer Biol 22:428-36
Concepcion, Carla P; Bonetti, Ciro; Ventura, Andrea (2012) The microRNA-17-92 family of microRNA clusters in development and disease. Cancer J 18:262-7
de Pontual, Loic; Yao, Evelyn; Callier, Patrick et al. (2011) Germline deletion of the miR-17ýýý92 cluster causes skeletal and growth defects in humans. Nat Genet 43:1026-30
Sage, Julien; Ventura, Andrea (2011) miR than meets the eye. Genes Dev 25:1663-7

Showing the most recent 10 out of 12 publications